Related Experiment Video
Updated: Aug 30, 2026
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
Identification of repertoires of surface antigens on leukemias using an antibody microarray
Larissa Belov1, Pauline Huang, Nicole Barber
1School of Molecular and Microbial Biosciences G08, University of Sydney, Sydney, NSW 2006, Australia.
Insights
This study introduces a refined microarray for identifying over 60 cluster of differentiation (CD) antigens on leukocytes, aiding in the diagnosis of hematological malignancies like leukemia and lymphoma.
Area of Science:
- Hematology
- Immunology
- Biotechnology
Background:
- Leukemias and lymphomas are hematological malignancies originating from distinct hematopoietic lineages.
- Accurate immunophenotyping is crucial for diagnosing these conditions.
Purpose of the Study:
- To present an enhanced microarray technology for high-throughput immunophenotyping of leukocytes.
- To demonstrate the utility of this technology in distinguishing between normal leukocytes and those found in hematological malignancies.
Main Methods:
- A microarray platform utilizing immobilized cluster of differentiation (CD) antibodies to capture whole leukocytes.
- Detection of CD antigens without requiring protein purification, labeling, or secondary detection systems.
- Analysis of distinct cellular binding patterns generated by the microarray.
Main Results:
- The refined microarray identifies over 60 CD antigens on leukocytes.
- Distinct binding patterns differentiate various leukemias and lymphomas from normal peripheral blood leukocytes.
- The technology provides an extensive immunophenotype for diagnosing common leukemias.
Conclusions:
- The developed microarray technology offers a robust method for the immunophenotypic diagnosis of hematological malignancies.
- This approach simplifies cell analysis by eliminating the need for complex sample preparation.
- Further evaluation is underway to integrate this technology with conventional diagnostic methods for leukemia diagnosis.
Abstract:
We have previously described a microarray of cluster of differentiation (CD) antibodies that enables concurrent determination of more than 60 CD antigens on leukocytes. This procedure does not require protein purification or labeling, or a secondary detection system. Whole cells are captured by a microarray of 10 nL antibody dots immobilized on a nitrocellulose film on a microscope slide. Distinct patterns of cell binding are observed for different leukemias or lymphomas. These haematological malignancies arise from precursor cells of T- or B-lymphocytic, or myeloid lineages of hematopoiesis. The dot patterns obtained from patients are distinct from those of peripheral blood leukocytes from normal subjects. This microarray technology has recently undergone a number of refinements. The microarray now contains more CD antibodies, and a scanner for imaging dot patterns and software for data analysis provide an extensive immunophenotype sufficient for diagnosis of common leukemias. The technology is being evaluated for diagnosis of leukemias with parallel use of conventional diagnostic criteria.
